Johnson & Johnson Innovation - JJDC, Inc., 10% Owner at ACHILLION PHARMACEUTICALS INC (ACHN), sold 36,734,692 shares at $2.75 ($101.0M) on 2017-11-20, disclosed to the SEC on 2017-11-22.
Open-market sale of $101.0M ACHN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.75 | 18,367,346 | $50.5M | 50.0% |
| 2 | $2.75 | 18,367,346 | $50.5M | 50.0% |
| Total | $2.75 avg | 36,734,692 | $101.0M | 100% |
| Filing → |
| CVRX | SELL | 2024-03-06 | $96K | — | Filing → |
| NVRO | SELL | 2016-02-12 | $48.5M | — | Filing → |